#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'

Kyle LaHucik

Senior Reporter

CHICAGO — This weekend, tens of thousands of physicians, clinical trial investigators, academics, R&D scientists and biopharma leaders descended upon Chicago for the first in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Autoimmune CAR-T data dump: Kyverna, Cabaletta shares fall after unveiling early-stage results

Rare pediatric disease vouchers face uncertain future after September

Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

Gilead cancer drug magrolimab showed worrying trends around death

De-risking the patient journey in cell therapies: Six key considerations

#AS­CO22: Min­gling face-to-face stole the spot­light in re­union with '50,000 of your clos­est friend­s'

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Au­toim­mune CAR-T da­ta dump: Kyver­na, Ca­balet­ta shares fall af­ter un­veil­ing ear­ly-stage re­sults

Rare pe­di­atric dis­ease vouch­ers face un­cer­tain fu­ture af­ter Sep­tem­ber

Stephen Squin­to talks writ­ing checks and next-gen obe­si­ty drugs as JP Mor­gan clos­es first $500M+ biotech fund

Ex­clu­sive: For­mer Mer­ck sci­en­tists raise $85M to map and drug pro­tein in­ter­ac­tions in can­cer and au­toim­mune dis­ease

Gilead can­cer drug ma­grolimab showed wor­ry­ing trends around death

De-risk­ing the pa­tient jour­ney in cell ther­a­pies: Six key con­sid­er­a­tions

#ASCO22: Mingling face-to-face stole the spotlight in reunion with '50,000 of your closest friends'

Autoimmune CAR-T data dump: Kyverna, Cabaletta shares fall after unveiling early-stage results

Rare pediatric disease vouchers face uncertain future after September

Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

Gilead cancer drug magrolimab showed worrying trends around death

De-risking the patient journey in cell therapies: Six key considerations